查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1706117

2025年门脉高压管理全球市场报告

Portal Hypertension Management Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年门静脉高压管理市场规模将强劲成长。到 2029 年，这一数字将成长至 42.3 亿美元，年复合成长率（CAGR）为 6.6%。预测期内的成长可归因于医疗保健基础设施投资的增加、医疗保险覆盖范围的扩大、有利的法规环境和加快的核准流程、专注于了解门静脉高压病理生理的持续研究和开发活动，以及透过远端监控技术促进持续的患者管理。预测期内的关键趋势包括远端医疗的日益普及、生物工程肝组织等医疗技术的持续进步、个人化医疗的日益增长趋势、针对个别患者特征的标靶治疗的开发以及包括弹性成像等非侵入性成像技术在内的诊断方法的改进。

由于肝炎等肝病的盛行率不断上升，门静脉高压管理市场预计将会成长。肝病包括多种影响肝臟结构和功能的疾病，常导致黄疸、疲劳和腹痛等症状。原因包括病毒感染、酗酒和代谢紊乱。肝病门静脉高压的治疗旨在降低门静脉系统的压力，从而减轻静脉曲张出血、腹水和肝性脑病变等併发症，并改善患者的预后。例如，澳洲癌症协会报告称，2022 年澳洲诊断出约 2,905 例新的肝癌病例，突显出发病率上升推动了市场成长。

门脉高压管理的主要企业正在开发微创设备，以改善治疗结果并最大限度地降低手术风险。这些仪器旨在以对组织的破坏最小的方式执行手术，通常透过小切口或自然的身体孔口进行。例如，美敦力公司于 2023 年 11 月获得 FDA核准其 Symplicity Spyral 肾臟去神经支配系统，该系统使用射频能源针对肾臟附近的神经来控制高血压。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球门脉高压症管理 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球门脉高压管理市场：成长率分析
  • 全球门脉高压管理市场表现：规模与成长，2019-2024
  • 全球门脉高压管理市场预测：规模与成长，2024-2029 年，2034 年
  • 全球门脉高压管理总目标市场（TAM）

第六章市场区隔

  • 全球门静脉高压管理市场（依治疗类型、表现和预测）：2019-2024 年、2024-2029 年、2034 年
  • 製药
  • 非手术治疗
  • 外科手术
  • 全球门脉高压管理市场（依手术类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 经颈静脉肝内门体分流术（TIPS）
  • 其他手术类型
  • 全球门脉高压管理市场（依最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 专科诊所
  • 其他最终用户
  • 全球门脉高压症管理市场，依药物类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • β受体阻断剂
  • 血管扩张剂
  • 利尿剂
  • 抗生素
  • 其他药物
  • 全球门脉高压管理市场，依非手术程序类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 内视镜静脉曲张结扎术（EVL）
  • 内视镜硬化疗法
  • 经颈静脉肝内门体分流术（TIPS）
  • 球囊阻塞
  • 全球门静脉高压管理市场，依手术类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 肝臟移植
  • 门体分流术
  • 门静脉减压手术
  • 其他外科手术

第七章 区域和国家分析

  • 全球门脉高压管理市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球门静脉高压管理市场：依国家、地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 门脉高压管理市场：竞争格局
  • 门脉高压管理市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • AstraZeneca PLC
  • Novartis AG
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Amgen Inc.
  • Gilead Sciences Inc.
  • Merck & Co.
  • Boehringer Ingelheim International GmbH
  • Amneal Pharmaceuticals LLC.
  • Lupin Ltd.
  • Daiichi Sankyo
  • Dr. Falk Pharma GmbH
  • Cumberland Pharmaceuticals Inc.
  • Ono Pharmaceutical Co. Ltd.
  • Chiasma Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年门脉高压管理市场：提供新机会的国家
  • 2029 年门脉高压管理市场：细分领域带来新机会
  • 2029 年门脉高压管理市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r30989

Portal hypertension management encompasses strategies aimed at treating and preventing complications arising from elevated pressure in the portal vein system, often associated with liver cirrhosis. These measures include lifestyle adjustments, medication administration (such as beta-blockers), and procedures such as variceal banding to prevent or treat complications such as variceal bleeding and ascites.

The primary approaches to portal hypertension management include medication, non-surgical procedures, and surgery. Medication for portal hypertension typically includes nonselective beta-blockers, vasoconstrictors, diuretics, and antibiotics, which are used to manage conditions such as variceal bleeding, ascites, and bacterial infections in patients with increased portal pressure. Non-surgical procedures involve techniques such as transjugular intrahepatic portosystemic shunt (TIPS), which is employed across various healthcare settings including hospitals, specialty clinics, and others.

The portal hypertension management research report is one of a series of new reports from The Business Research Company that provides portal hypertension management market statistics, including the portal hypertension management industry's global market size, regional shares, competitors with a portal hypertension management market share, detailed portal hypertension management market segments, market trends and opportunities, and any further data you may need to thrive in the portal hypertension management industry. This portal hypertension management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The portal hypertension management market size has grown strongly in recent years. It will grow from $3.07 billion in 2024 to $3.28 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to the increased prevalence of liver diseases, growth in the geriatric population, awareness and screening programs, economic burden of liver diseases, approval done for new drugs and therapies, and improvement done for diagnostic methods.

The portal hypertension management market size is expected to see strong growth in the next few years. It will grow to $4.23 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising investment in healthcare infrastructure, broader health insurance coverage, favorable regulatory environments and expedited approval processes, ongoing r&d activities focused on understanding the pathophysiology of portal hypertension, and remote monitoring technologies will facilitate continuous patient management. Major trends in the forecast period include growing adoption of telemedicine, continued advancements in medical technology, such as bio-engineered liver tissue, growth in personalized medicine, development of targeted therapies tailored to individual patient profiles, improved diagnostic methods, including non-invasive imaging technologies like elastography.

The portal hypertension management market is poised for growth due to an increasing prevalence of liver diseases such as hepatitis. Liver diseases encompass a spectrum of conditions affecting liver structure and function, often resulting in symptoms such as jaundice, fatigue, and abdominal pain. Causes include viral infections, alcohol abuse, and metabolic disorders. Management of portal hypertension in liver disease aims to alleviate complications such as variceal bleeding, ascites, and hepatic encephalopathy by reducing pressure in the portal vein system, thereby improving patient outcomes. For example, in 2022, Cancer Australia reported approximately 2,905 new cases of liver cancer diagnosed in Australia, underscoring the rising incidence contributing to market growth.

Leading companies in the portal hypertension management sector are advancing minimally invasive devices to enhance treatment efficacy and minimize procedural risks. These devices are designed to perform procedures with minimal disruption to tissues, typically through small incisions or natural body openings. For instance, Medtronic Plc received FDA approval in November 2023 for the Symplicity Spyral renal denervation system, utilizing radiofrequency energy to manage hypertension by targeting nerves near the kidneys.

In February 2023, AstraZeneca Plc acquired CinCor Pharma Inc. for $1.8 billion. This acquisition enriches AstraZeneca's portfolio with CinCor's barostat (CIN-107), an aldosterone synthase inhibitor designed to lower blood pressure in treatment-resistant hypertension. CinCor Pharma Inc., based in the US, specializes in developing innovative medications for hypertension management.

Major companies operating in the portal hypertension management market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Merck & Co., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals LLC., Lupin Ltd., Daiichi Sankyo, Dr. Falk Pharma GmbH, Cumberland Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Chiasma Inc., Debiovision Inc.

North America was the largest region in the portal hypertension management market in 2024. The regions covered in the portal hypertension management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the portal hypertension management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The portal hypertension management market consists of revenues earned by entities by provide services such as medical management, endoscopic therapy, interventional radiology procedures, and monitoring and supportive care. The market value includes the value of related goods sold by the service provider or included within the service offering. The portal hypertension management market also includes sales of nonselective beta-blockers, and vasoconstrictors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Portal Hypertension Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on portal hypertension management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for portal hypertension management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The portal hypertension management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Treatment Type: Medications; Non-Surgical Procedures; Surgery
  • 2) By Procedure Type: Transjugular Intrahepatic Portosystemic Shunt (TIPS); Other Procedure Types
  • 3) By End-User: Hospitals; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Medications: Beta-Blockers; Vasodilators; Diuretics; Antibiotics; Other Medications
  • 2) By Non-Surgical Procedures: Endoscopic Variceal Ligation (EVL); Endoscopic Sclerotherapy; Transjugular Intrahepatic Portosystemic Shunt (TIPS); Balloon Occlusion
  • 3) By Surgery: Liver Transplantation; Portosystemic Shunt Surgery; Surgical Decompression Of Portal Vein; Other Surgical Procedures
  • Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Portal Hypertension Management Market Characteristics

3. Portal Hypertension Management Market Trends And Strategies

4. Portal Hypertension Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Portal Hypertension Management Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Portal Hypertension Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Portal Hypertension Management Market Growth Rate Analysis
  • 5.4. Global Portal Hypertension Management Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Portal Hypertension Management Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Portal Hypertension Management Total Addressable Market (TAM)

6. Portal Hypertension Management Market Segmentation

  • 6.1. Global Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medications
  • Non-Surgical Procedures
  • Surgery
  • 6.2. Global Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transjugular Intrahepatic Portosystemic Shunt (TIPS)
  • Other Procedure Types
  • 6.3. Global Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End-Users
  • 6.4. Global Portal Hypertension Management Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Beta-Blockers
  • Vasodilators
  • Diuretics
  • Antibiotics
  • Other Medications
  • 6.5. Global Portal Hypertension Management Market, Sub-Segmentation Of Non-Surgical Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endoscopic Variceal Ligation (EVL)
  • Endoscopic Sclerotherapy
  • Transjugular Intrahepatic Portosystemic Shunt (TIPS)
  • Balloon Occlusion
  • 6.6. Global Portal Hypertension Management Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Transplantation
  • Portosystemic Shunt Surgery
  • Surgical Decompression Of Portal Vein
  • Other Surgical Procedures

7. Portal Hypertension Management Market Regional And Country Analysis

  • 7.1. Global Portal Hypertension Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Portal Hypertension Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Portal Hypertension Management Market

  • 8.1. Asia-Pacific Portal Hypertension Management Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Portal Hypertension Management Market

  • 9.1. China Portal Hypertension Management Market Overview
  • 9.2. China Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Portal Hypertension Management Market

  • 10.1. India Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Portal Hypertension Management Market

  • 11.1. Japan Portal Hypertension Management Market Overview
  • 11.2. Japan Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Portal Hypertension Management Market

  • 12.1. Australia Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Portal Hypertension Management Market

  • 13.1. Indonesia Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Portal Hypertension Management Market

  • 14.1. South Korea Portal Hypertension Management Market Overview
  • 14.2. South Korea Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Portal Hypertension Management Market

  • 15.1. Western Europe Portal Hypertension Management Market Overview
  • 15.2. Western Europe Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Portal Hypertension Management Market

  • 16.1. UK Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Portal Hypertension Management Market

  • 17.1. Germany Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Portal Hypertension Management Market

  • 18.1. France Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Portal Hypertension Management Market

  • 19.1. Italy Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Portal Hypertension Management Market

  • 20.1. Spain Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Portal Hypertension Management Market

  • 21.1. Eastern Europe Portal Hypertension Management Market Overview
  • 21.2. Eastern Europe Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Portal Hypertension Management Market

  • 22.1. Russia Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Portal Hypertension Management Market

  • 23.1. North America Portal Hypertension Management Market Overview
  • 23.2. North America Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Portal Hypertension Management Market

  • 24.1. USA Portal Hypertension Management Market Overview
  • 24.2. USA Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Portal Hypertension Management Market

  • 25.1. Canada Portal Hypertension Management Market Overview
  • 25.2. Canada Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Portal Hypertension Management Market

  • 26.1. South America Portal Hypertension Management Market Overview
  • 26.2. South America Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Portal Hypertension Management Market

  • 27.1. Brazil Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Portal Hypertension Management Market

  • 28.1. Middle East Portal Hypertension Management Market Overview
  • 28.2. Middle East Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Portal Hypertension Management Market

  • 29.1. Africa Portal Hypertension Management Market Overview
  • 29.2. Africa Portal Hypertension Management Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Portal Hypertension Management Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Portal Hypertension Management Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Portal Hypertension Management Market Competitive Landscape And Company Profiles

  • 30.1. Portal Hypertension Management Market Competitive Landscape
  • 30.2. Portal Hypertension Management Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Portal Hypertension Management Market Other Major And Innovative Companies

  • 31.1. AstraZeneca PLC
  • 31.2. Novartis AG
  • 31.3. GlaxoSmithKline plc
  • 31.4. Eli Lilly and Company
  • 31.5. Amgen Inc.
  • 31.6. Gilead Sciences Inc.
  • 31.7. Merck & Co.
  • 31.8. Boehringer Ingelheim International GmbH
  • 31.9. Amneal Pharmaceuticals LLC.
  • 31.10. Lupin Ltd.
  • 31.11. Daiichi Sankyo
  • 31.12. Dr. Falk Pharma GmbH
  • 31.13. Cumberland Pharmaceuticals Inc.
  • 31.14. Ono Pharmaceutical Co. Ltd.
  • 31.15. Chiasma Inc.

32. Global Portal Hypertension Management Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Portal Hypertension Management Market

34. Recent Developments In The Portal Hypertension Management Market

35. Portal Hypertension Management Market High Potential Countries, Segments and Strategies

  • 35.1 Portal Hypertension Management Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Portal Hypertension Management Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Portal Hypertension Management Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer